Alexandria Hammond is a Vice President on the US Biopharmaceuticals Equity Research team, covering Major Pharma and Large & SMid Cap Biotechnology. She has a PhD from NYU School of Medicine in Microbiology and a BS in Cell and Molecular Biology from Binghamton University.